Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of thyroid autoantibodies.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

DHT, not testosterone, mainly affects hair growth and related conditions.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Dermatologists should guide patients on blood donation timing due to various eligibility criteria.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

A stem cell-derived matrix speeds up healing of diabetic skin wounds.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Applying calreticulin can speed up wound healing in diabetics.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Specific brain and bone imaging findings can help diagnose Trichothiodystrophy.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

People with severe Alopecia Areata have higher levels of TGF-β1, which may play a role in the condition.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

DPP4, a molecule in skin, helps heal large wounds and regrow hair follicles when its levels are reduced.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Duodenal mucosal resurfacing did not improve insulin sensitivity or reproductive function in women with PCOS.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

IL-25 helps heal diabetic wounds by improving blood vessel and skin cell functions.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.